NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics revenues increased 7 percent year over year, surpassing the overall growth of the firm's diagnostics division.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 10.27 billion $11.22 billion), up 5 percent from CHF 9.74 billion in 2011. On a constant currency basis, revenues were up 4 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.